← Leaderboards
Joy Marie Schmitz
University Of Texas Hlth Sci Ctr Houston
$16,485,851
Attributed
$23,098,503
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,248,277 · 18
By mechanism
R01$15,109,006 · 10
P50$10,703,640 · 5
U01$3,119,619 · 1
P30$316,012 · 2
Top collaborators
- Scott D Lane9 shared
- Rodrigo Grassi-Oliveira6 shared
- Consuelo Walss-Bass6 shared
- L. Elliot Hong1 shared
- Francesco Versace1 shared
- Heather E Webber1 shared
- Luba Yammine1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Scott D Lane$7,455,327
- Heather E Webber$1,721,558
- Jacquelyn Slomka$2,068,259
- Luba Yammine$1,357,533
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocaineClinical TrialsResponseBaseBehavioralCocaine UsePharmaceutical PreparationsPlacebosAddictionBehavior TherapyChronicUrineLevodopaMediatingCocaine DependencesEvidence BaseRelapseSubstance Use DisorderBehavioral /Social Science Research TagDouble-Blind MethodAbstinenceAffectPharmacotherapyBrain Region
Grant awards (64)
Contingency management plus deep transcranial magnetic stimulation for the treatment of cocaine use disorder$3,119,619
U01 · FY2025 · DA · contact PI
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study$702,965
R01 · FY2025 · DA
Substance Use Scientific Working Group$24,561
P30 · FY2025 · AI · contact PI
Substance Use Scientific Working Group$30,930
P30 · FY2024 · AI · contact PI
Pioglitazone as an adjunct to CBT for cocaine relapse prevention$534,804
R01 · FY2023 · DA · contact PI
Substance Use Scientific Working Group$34,592
P30 · FY2023 · AI · contact PI
Pioglitazone as an adjunct to CBT for cocaine relapse prevention$664,976
R01 · FY2022 · DA · contact PI
Substance Use Scientific Working Group$196,728
P30 · FY2022 · AI · contact PI
Pioglitazone as an adjunct to CBT for cocaine relapse prevention$664,976
R01 · FY2021 · DA · contact PI
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine Addiction$503,777
R01 · FY2021 · DA · contact PI
Substance Use Scientific Working Group$29,201
P30 · FY2021 · AI · contact PI
Pioglitazone as an adjunct to CBT for cocaine relapse prevention$663,103
R01 · FY2020 · DA · contact PI
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine Addiction$503,777
R01 · FY2020 · DA · contact PI
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine Addiction$503,777
R01 · FY2019 · DA · contact PI
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention$490,736
R01 · FY2019 · DA · contact PI
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine Addiction$503,777
R01 · FY2018 · DA · contact PI
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention$490,736
R01 · FY2018 · DA · contact PI
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine Addiction$152,460
R01 · FY2018 · DA · contact PI
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine Addiction$616,475
R01 · FY2017 · DA · contact PI
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention$490,736
R01 · FY2017 · DA · contact PI
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention$476,257
R01 · FY2016 · DA · contact PI
Substance Abuse Research - Medications Development Center$2,054,493
P50 · FY2014 · DA · contact PI
Cognitive-enhancing DA Medications for Cocaine Dependence$382,564
R01 · FY2014 · DA · contact PI
Clinical trial of citalopram in cocaine dependence$254,414
P50 · FY2014 · DA · contact PI
Substance Abuse Research - Medications Development Center$1,996,512
P50 · FY2013 · DA · contact PI
Cognitive-enhancing DA Medications for Cocaine Dependence$371,760
R01 · FY2013 · DA · contact PI
Clinical trial of citalopram in cocaine dependence$278,374
P50 · FY2013 · DA · contact PI
Adaptive Clinical Trial of Adenosine A2a Antagonist in Cocaine Dependence$3
P50 · FY2013 · DA · contact PI
Substance Abuse Research - Medications Development Center$2,098,769
P50 · FY2012 · DA · contact PI
Cognitive-enhancing DA Medications for Cocaine Dependence$388,148
R01 · FY2012 · DA · contact PI
Clinical trial of citalopram in cocaine dependence$310,804
P50 · FY2012 · DA · contact PI
Cognitive-enhancing DA Medications for Cocaine Dependence$377,360
R01 · FY2011 · DA · contact PI
Clinical trial of citalopram in cocaine dependence$241,677
P50 · FY2011 · DA · contact PI
Adaptive Clinical Trial of Adenosine A2a Antagonist in Cocaine Dependence$2
P50 · FY2011 · DA · contact PI
Cognitive-enhancing DA Medications for Cocaine Dependence$368,777
R01 · FY2010 · DA · contact PI
Contingency Management plus Levodopa/Carbidopa for Trtment. of Cocaine Dependence$360,187
R01 · FY2010 · DA · contact PI
Clinical Trial of Dopamine-Serotonin Medication Combination in Cocaine Dependence$244,985
P50 · FY2010 · DA · contact PI
Adaptive Clinical Trial of Adenosine A2a Antagonist in Cocaine Dependence$2
P50 · FY2010 · DA · contact PI
PHARMACOTHERAPY DOSING REGIMEN$490,822
P50 · FY2009 · DA · contact PI
Contingency Management plus Levodopa/Carbidopa for Trtment. of Cocaine Dependence$363,825
R01 · FY2009 · DA · contact PI
SCREENING MEDICATIONS FOR COCAINE CESSATION & RELAPSE PREVENTION$315,450
P50 · FY2009 · DA · contact PI
PHARMACOTHERAPY DOSING REGIMEN$410,989
P50 · FY2008 · DA · contact PI
Contingency Management plus Levodopa/Carbidopa for Trtment. of Cocaine Dependence$363,825
R01 · FY2008 · DA · contact PI
SCREENING MEDICATIONS FOR COCAINE CESSATION & RELAPSE PREVENTION$283,793
P50 · FY2008 · DA · contact PI
SCREENING MEDICATIONS FOR COCAINE CESSATION & RELAPSE PREVENTION$669,449
P50 · FY2007 · DA · contact PI
Contingency Management plus Levodopa/Carbidopa for Trtment. of Cocaine Dependence$371,250
R01 · FY2007 · DA · contact PI
MEDICATIONS FOR COCAINE CESSATION /RELAPSE PREVENTION$392,402
P50 · FY2006 · DA · contact PI
Combined Treatment for Cocaine-Alcohol Dependence$369,394
R01 · FY2005 · DA
MEDICATIONS FOR COCAINE CESSATION /RELAPSE PREVENTION$315,821
P50 · FY2005 · DA
Combined Treatment for Cocaine-Alcohol Dependence$334,125
R01 · FY2004 · DA
Combined Treatment for Cocaine-Alcohol Dependence$64,686
R01 · FY2004 · DA
Combined Treatment for Cocaine-Alcohol Dependence$334,313
R01 · FY2003 · DA
INTEGRATED TREATMENT FOR COCAINE AND MOOD DISORDERS$223,500
R01 · FY2003 · DA
INTEGRATED TREATMENT FOR COCAINE AND MOOD DISORDERS$335,438
R01 · FY2002 · DA
Combined Treatment for Cocaine-Alcohol Dependence$333,780
R01 · FY2002 · DA
Behavioral Strategies to maximixe pharmacotherapy efficacy for Cocaine dependence$0
P50 · FY2002 · DA
INTEGRATED TREATMENT FOR COCAINE AND MOOD DISORDERS$336,375
R01 · FY2001 · DA
BEH PHARM TREATMENTS FOR ALCOHOL/NICOTINE DEPENDENCE$327,353
R01 · FY2001 · AA
PREVENTION OF SMOKING RELAPSE IN WOMEN$227,434
R01 · FY2001 · DA
Behavioral Strategies to maximixe pharmacotherapy efficacy for Cocaine dependence$0
P50 · FY2001 · DA
Behavioral Strategies to maximixe pharmacotherapy efficacy for Cocaine dependence$344,879
P50 · FY2000 · DA
INTEGRATED TREATMENT FOR COCAINE AND MOOD DISORDERS$334,791
R01 · FY2000 · DA
BEH PHARM TREATMENTS FOR ALCOHOL/NICOTINE DEPENDENCE$317,818
R01 · FY2000 · AA
PREVENTION OF SMOKING RELAPSE IN WOMEN$258,971
R01 · FY2000 · DA